Clinical Trial Update: Amyloid Beta and Cognition in Parkinson Disease

View source ↗

Summary

This clinical trial update confirms completion of a study investigating amyloid beta and cognition in Parkinson's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Snippet

Sponsor: University of Michigan | Conditions: Parkinson Disease, Neurological Disorders | Status: COMPLETED